EPCCS 2019 Monika Hollander asks Peter van der Meer how comorbidities like renal dysfunction and cancer treatment affects management of patients with HF: what is known about treatment in patients with these comorbidities?
This video was recorded during the two-day EPCCS CV Summit and aims to give an impression of the presentation given by prof. Van der Meer.
Peter van der Meer is Professor of Heart Failure and Translational Cardiology at the University of Groningen and director of the coronary care unit of the University Medical Center Groningen, The Netherlands.
Dr. Monika Hollander - General Practitioner, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS. No funding was obtained for the recording of this video.
What is known about effect of treatment in HF patients with renal dysfunction? 0:36
How to manage patients with fluid overload and renal dysfunction? 1:44
Potential cardiotoxic side-effects of cancer treatment 3:24
